G Medical Innovations Holdings Ltd. (GMVD) News
Filter GMVD News Items
GMVD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest GMVD News From Around the Web
Below are the latest news stories about G MEDICAL INNOVATIONS HOLDINGS LTD that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday! |
G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.Irvine, California, Dec. 05, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that it received 2 (Two) granted patents from the United States Patent and Trademark office for its monitoring products marketed in the U.S. market. The granted patents are: METHOD, DEVICE AND SYSTEM FOR NON-INVESIVELY MONITORING PHYSIOLOGICAL PARAMETERS This patent integrates sensing mechanism that allows the monitoring system to ana |
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing RequirementsIrvine, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received today a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is no longer in compliance with the minimum shareholders’ equity requirement for continued listing |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! |
G Medical Innovations Announces First Half 2022 Financial Results and Provides Business UpdateIrvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical” or the “Company”), an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms, today announced its financial results and provided a business update for the six months ended June 30, 2022. First Half 2022 Financial Results During the six months period ended June 30, 2022, the Company perfor |
G Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours resultsOctober 6, 2022 IRVINE, California, Oct. 06, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that its wholly owned subsidiary, G. Medical Health and Wellness, Inc., has developed 31 different at-home health tests kits that are expected to be available to consumers during Q4-2022 through online and later popular big-box retail sites and pharmacies across the United States. The first 7 new health testing kits we |
G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick resultsThe first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies The tests offered to the consumers utilize FDA registered componentsTest kit prices range from $50-$260, all provide results within days by CLIA certified labsAdditional testing kits to be announced l |
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price NotificationIrvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Lis |
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase ProgramIrvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, tr |
G Medical Warns On Missing Q1 Sales Guidance Of $30MView more earnings on GMVDSee more from BenzingaCDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis: CNBCThird Largest Player In Baby Formula Jumps In To Ease Shortage In USDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. |